Rates of Severe COVID-19 Lower With Nirmatrelvir in ≥65s

THURSDAY, Aug. 25, 2022 -- For adults aged 65 years or older, nirmatrelvir is associated with reduced rates of hospitalization and death due to COVID-19, according to a study published online Aug. 24 in the New England Journal of Medicine.
Ronen...